All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2025-N-6895
Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments--Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List
Documents
1
Comments
48
Description
Open
Key Dates
Comment Period OpensApr 16, 2026
Comment Period ClosesJul 23, 2026
Documents
Comment Statistics
Total Comments
48
Keywords
CDER
FRDTS # 2025-644
Pharmacy Compounding Advisory Committee
Notice of Meeting
Establishment of a Public Docket
Request for Comments--Bulk Drug Substances
Nominated for Inclusion on the Section 503A
Bulk Drug Substances List
Data from Regulations.gov